HomeSafetyGastroparesis

Safety topic

GLP-1 medications and gastroparesis (delayed gastric emptying)

Delayed gastric emptying is the deliberate mechanism of GLP-1 β€” that is not pathologic gastroparesis. True chronic gastroparesis after GLP-1 is rare; symptoms past week 8 at stable dose warrant evaluation.

Rare but serious

Who should not take this

  • Pre-existing severe gastroparesis (relative)
  • Pre-existing severe gastrointestinal disease (relative)

How it happens

GLP-1 receptor activation delays gastric emptying as part of its therapeutic action β€” producing satiety and slower nutrient absorption. This is reversible on stopping the drug. True gastroparesis (chronically delayed emptying that persists off-drug) has been reported in case series but the causal attribution is debated; many cases involve pre-existing diabetes-related gastroparesis.

Red flags β€” when to seek care

  • Severe nausea + vomiting persisting past week 8 at a stable dose
  • Persistent post-meal fullness lasting hours
  • Dehydration from inability to keep fluids down

What to do

  1. 1.Persistent severe GI symptoms past week 8 at stable dose warrants a gastric-emptying study (scintigraphy)
  2. 2.Discuss dose reduction or molecule switch (semaglutide ↔ tirzepatide) with your prescriber
  3. 3.Stop GLP-1 immediately for persistent intractable vomiting

Affected medications

Sources

People also ask

Common questions readers ask

Can you drink alcohol on Wegovy?
No hard contraindication, but alcohol tolerance often drops sharply on GLP-1. Many patients also report reduced desire for alcohol β€” likely a secondary effect of GLP-1 on the brain reward system.
Full evidence-graded answer
Does GLP-1 affect oral birth control?
Tirzepatide (Mounjaro, Zepbound) has documented reduced absorption of oral contraceptives during the first 4 weeks of each dose increase. Use backup contraception for ~4 weeks after starting + after each step-up. Semaglutide has no documented effect.
Full evidence-graded answer
Can I take GLP-1 while pregnant?
No. All FDA-approved GLP-1s carry a pregnancy contraindication. Stop GLP-1 at least 2 months before planned conception due to its long half-life.
Full evidence-graded answer
Is it safe to take GLP-1 long-term?
Liraglutide has 15+ years of post-marketing data (Victoza approved 2010). Semaglutide has 8+ years (Ozempic approved 2017). No new class-wide safety signals have emerged in extended follow-up. Chronic use is the FDA-approved indication for both T2D and obesity.
Full evidence-graded answer

Editorial information based on FDA prescribing data + peer-reviewed sources as of 2026. Not personal medical advice. Reviewed by Jane Novak, MD, MPH.